Handbook of Endocannabinoid Function in the Central Nervous System

Handbook of Endocannabinoid Function in the Central Nervous System, a new release in the Handbook of Behavioral Neuroscience series, offers a comprehensive, interdisciplinary approach to understanding the role of the endocannabinoid system in functions of the central nervous system. This new volume brings together the most influential and internally recognized experts in the field to provide a detailed overview of the physiological and pathophysiological roles of endocannabinoids in CNS activity. It covers the history, functional anatomy, and neurophysiology of the endocannabinoid system, moving on to assess endocannabinoid roles across human lifespans, and in behavioral control.

Final sections of the book explore the use of endocannabinoids in psychiatric and neurological disorders. This is a vital resource for neuroscientists, neuropharmacologists, and neuropathologists, as well as any researcher seeking detailed discussions of brain endocannabinoid functions.

• Presents a new volume in the Handbook of Behavioral Neuroscience series
• Examines endocannabinoid use and function in psychiatric disorders such as anxiety, depression, substance abuse, and more
• Assesses the use of endocannabinoids in treating mental disorders, including Parkinson’s and Alzheimer’s
• Discusses preclinical to clinical levels of investigation

Olivier Manzoni is a Research Director at INSERM in Marseille and director of the International Associated Laboratory CannaLab (University of Indiana, Bloomington USA / Aix-Marseille University, France). His research is centered on understanding the molecular basis of synaptic plasticity in normal and pathological conditions, with a focus on the function of the endocannabinoid system and the effects of cannabis during lifetime.

Vivana Trezza is an Associate Professor and Group Leader at Roma Tre University. Her research investigates the brain mechanisms underlying functional and dysfunctional socio-emotional behavior, to identify novel pharmacological targets for neuropsychiatric and neurodevelopmental disorders characterized by aberrant socio-emotional processing. A special emphasis in her research is placed on the role of the endocannabinoid system in the regulation of emotions and cognition through development.